Documentos relacionados

1. Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.
2. Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease.
3. Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.
4. Phenylbenzothiazole derivatives: effects against a Trypanosoma cruzi infection and toxicological profiles.
5. B-Cell Responses in Chronic Chagas Disease: Waning of Trypanosoma cruzi-Specific Antibody-Secreting Cells Following Successful Etiological Treatment.
6. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
7. Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice.
8. Chagas disease in immunocompromised patients.
9. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.
10. Benzonidazole treatment has a beneficial effect on cells infected with the Colombian strain of Trypanosoma cruzi.